EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tacrolimus (FK506) Attenuates Hepatic Ischemia–Reperfusion Injury via Oxidative Glutathione Metabolism and Suppression of Lipoxygenase-Mediated Cell Death

Moritz Drefs iD, Malte J Schirren iD, Dominik T Koch iD, Severin J Jacobi iD, Michael Neuberger iD, Lesca M Holdt, Bernhard W Renz iD, Jens Werner, Markus O Guba iD, Dionysios Koliogiannis iD

Antioxidants · 28.04.2026 · 15 (5) · 557

DOI: 10.3390/antiox15050557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 28.04.2026. Verfasst von Moritz Drefs und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral and Transplantation Surgery, LMU University Hospital, Ludwig Maximilian University, 81377 Munich, Germany. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatic ischemia–reperfusion injury (IRI) remains a major challenge in liver transplantation (LTx) and hepatectomy. Previous studies identified a 12/15-lipoxygenase (12/15-LOX)-driven lipid peroxidation cascade promoting cell death, whereas glutathione peroxidase 4 (GPx4)-dependent metabolism acts antagonistically. This study investigated whether tacrolimus protects against hepatic IRI through this redox axis.

Methods

Male C57BL/6 mice underwent 65% partial hepatic warm ischemia and reperfusion with or without tacrolimus preconditioning. Liver tissue and serum were analyzed by spectral photometry, Western blotting, TUNEL assay, and serum enzyme measurement. Results were statistically analyzed and compared with previously published results of 12/15-LOX inhibition by baicalein pretreatment and its carrier DMSO. Also, the combination of both tacrolimus and baicalein was investigated.

Results

Tacrolimus increased the oxidative glutathione activity quotient (GSSG/GSH) by 75.1% (p = 0.0302), attenuated MAPK signaling, reduced SAPK/JNK by 84.6% (p = 0.0059), with ERK1/2 showing a downward trend, decreased Caspase-3 activation by 66.9% (p < 0.001) and PARP cleavage by 59.9% (p = 0.0330), and lowered TUNEL-positive cell death by 61.8% (p = 0.0015). Tacrolimus achieved hepatoprotection comparable to 12/15-LOX inhibition, but without hepatotoxicity, whereas combined treatment conferred no additional benefit yet bore toxic properties.

Conclusions

Tacrolimus preconditioning mitigates hepatic IRI through a glutathione-linked redox–signaling–cell death axis and exerts cytoprotective effects beyond immunosuppression.

Schlagwörter

Stichwörter der Autor:innen

12/15-lipoxygenaseapoptosisferroptosisglutathione peroxidase 4hepatic ischemia–reperfusion injuryliver transplantationnecroptosisprogrammed cell deathreactive oxygen speciestacrolimus

Autor:innen und Institutionen

  • Department of General, Visceral and Transplantation Surgery, LMU University Hospital, Ludwig Maximilian University, 81377 Munich, Germany.
  • Institute of Surgical Research at the Walter Brendel Centre of Experimental Medicine, LMU University Hospital, Ludwig Maximilian University, 81377 Munich, Germany.
  • Institute of Laboratory Medicine, LMU University Hospital, Ludwig Maximilian University, 81377 Munich, Germany.
  • Faculty of Medicine, Ludwig Maximilian University, 80539 Munich, Germany.
  • Transplantation Center Munich, LMU University Hospital, Ludwig Maximilian University, 81377 Munich, Germany.

ORCID-Profile: Moritz Drefs, Malte J Schirren, Dominik T Koch, Severin J Jacobi, Michael Neuberger, Bernhard W Renz, Markus O Guba, Dionysios Koliogiannis

Zitieren

APA

Drefs, M., Schirren, M. J., Koch, D. T., Jacobi, S. J., Neuberger, M., Holdt, L. M., Renz, B. W., Werner, J., Guba, M. O., & Koliogiannis, D. (2026). Tacrolimus (FK506) Attenuates Hepatic Ischemia–Reperfusion Injury via Oxidative Glutathione Metabolism and Suppression of Lipoxygenase-Mediated Cell Death. Antioxidants, 15(5), 557. https://doi.org/10.3390/antiox15050557

Vancouver

Drefs M, Schirren MJ, Koch DT, Jacobi SJ, Neuberger M, Holdt LM, et al. Tacrolimus (FK506) Attenuates Hepatic Ischemia–Reperfusion Injury via Oxidative Glutathione Metabolism and Suppression of Lipoxygenase-Mediated Cell Death. Antioxidants. 2026;15(5):557. doi:10.3390/antiox15050557

BibTeX
@article{Drefs2026,
  author = {Drefs, Moritz and Schirren, Malte J and Koch, Dominik T and Jacobi, Severin J and Neuberger, Michael and Holdt, Lesca M and Renz, Bernhard W and Werner, Jens and Guba, Markus O and Koliogiannis, Dionysios},
  title = {Tacrolimus (FK506) Attenuates Hepatic Ischemia–Reperfusion Injury via Oxidative Glutathione Metabolism and Suppression of Lipoxygenase-Mediated Cell Death},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {557},
  doi = {10.3390/antiox15050557}
}
Kostenlos starten →